Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve supply chain risks with this anhydrous-free 1,2,4-triazolyl arylamine synthesis. Cheap starting materials, high yield, and scalable to 100MT/yr for drug development.
Solve indole synthesis challenges with this one-step nickel-catalyzed method. Achieve 92% yields, broad functional group tolerance, and simplified post-processing for cost-effective API production.
Solve isomer formation and pre-synthesis challenges in trifluoromethyl enaminone production. Achieve high-yield, gram-scale manufacturing with functional group tolerance for pharma R&D and supply chain stability.
Eliminate CO gas handling risks & reduce costs by 30% with this scalable multi-component synthesis for high-purity pharmaceutical intermediates. Contact us for custom production.
Solve N-aryl imine allylation challenges with this metal-free, air-tolerant process. Achieve 94% yields and eliminate expensive anhydrous equipment. Contact for CDMO scale-up.
Solve N-aryl imine allylation challenges with this metal-free, air-stable method. Achieve 85-94% yields at room temperature, reducing equipment costs and supply chain risks for API synthesis.
Discover cost-effective, scalable synthesis of indolo[2,1a]isoquinoline compounds with 90-110°C palladium-catalyzed carbonylation. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Discover a cost-effective, high-yield synthesis of 3-arylquinoline-2(1H) ketone derivatives using palladium-catalyzed aminocarbonylation. Ideal for API production with broad functional group tolerance and scalable to 100 MT/yr.
Solve aliskiren production challenges: low yield, complex purification. New method ensures high purity, cost efficiency, and scalable manufacturing.
Discover a novel, high-yield synthesis method for spiro[indene-isoindolinone] compounds with mild reaction conditions. Ideal for pharmaceutical R&D and production, reducing costs and safety risks.
Discover a scalable, eco-friendly synthesis route for KRAS inhibitor intermediate with 33% yield. Reduce costs and supply chain risks for your API production.
Avoid unstable reagents and improve yield in procaterol hydrochloride synthesis. Our CDMO expertise ensures reliable, high-purity production for your drug development.
Solve 4-step synthesis challenges with 3-step, 74% yield, 98.2% purity process. Avoid CO2/THF hazards. Scale to 100MT/yr for API intermediates.
Discover how enaminone synthesis with mild conditions and high yields solves supply chain risks for pharma intermediates. Reduce costs and scale efficiently.
Solve low-yield & heavy metal issues in ramipril intermediate production. 85-99% purity, 85-99% yield, eco-friendly process. Scale to 100 MT/yr with CDMO expertise.
Solve low-yield & high-cost issues in triazole synthesis. Our CDMO expertise enables 92% yield, 60°C mild conditions, and dual-functional groups for drug development.
Solve high-cost, multi-step synthesis of Vibegron intermediates. New phosphine-free route reduces waste, improves yield, and ensures supply chain stability for OAB drug production.
Solve OAB drug supply chain risks with 4-step metal-free synthesis. 95% yield, no phosphine waste. Reduce production costs by 30%.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Solve wastewater challenges in ribavirin intermediate manufacturing. New 3-step synthesis cuts waste by 70% with 84% yield. Ensure supply chain stability for API production.